13F-HR filed by Cormorant Asset Management, LP
Cormorant Asset Management, LP filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-14, with 65 holding rows worth $1,538,535,000.
- Accession
- 0001583977-18-000005
- Filer
- CIK 1583977
- Filed
- 2018-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2018
A holdings report, 65 entries on the cover page, a total value of $1,538,535,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,538,535,000 with VALUE read as thousands by filing date, 13F file number 028-15949. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerChen Bihua028-15950
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ANAPTYSBIO INC | 032724106 | COM | 1,135,000 | $113,239,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,810,000 | $85,251,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 1,370,000 | $83,515,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 1,328,400 | $80,979,000 | thousands by filing date | call |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 1,492,784 | $77,431,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 4,172,498 | $74,187,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 3,556,669 | $54,275,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 660,000 | $53,962,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 1,250,000 | $48,763,000 | thousands by filing date | |
| Inflarx Nv | N44821101 | COM | 1,341,540 | $46,042,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 700,000 | $45,640,000 | thousands by filing date | |
| PRINCIPIA BIOPHARMA INC | 74257L108 | COM | 1,486,898 | $43,447,000 | thousands by filing date | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 1,326,136 | $40,673,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,500,659 | $36,946,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 4,850,000 | $36,618,000 | thousands by filing date | |
| THERAVANCE BIOPHARMA INC | G8807B106 | COM | 1,100,000 | $35,937,000 | thousands by filing date | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 640,481 | $33,491,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,552,911 | $33,248,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 670,513 | $31,635,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 380,000 | $29,663,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 1,136,900 | $27,752,000 | thousands by filing date | call |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 190,000 | $26,838,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 350,000 | $24,801,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 500,000 | $24,800,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 1,000,000 | $24,410,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 734,588 | $22,442,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 175,000 | $21,516,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 831,000 | $21,191,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 500,000 | $19,505,000 | thousands by filing date | call |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 410,000 | $18,868,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 260,000 | $17,961,000 | thousands by filing date | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 808,166 | $15,743,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 190,000 | $14,410,000 | thousands by filing date | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 300,000 | $12,624,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 250,000 | $12,400,000 | thousands by filing date | call |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 260,000 | $9,763,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 600,000 | $9,120,000 | thousands by filing date | |
| RUBIUS THERAPEUTICS INC | 78116T103 | COM | 364,559 | $8,749,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 1,271,687 | $8,558,000 | thousands by filing date | |
| SPECTRUM PHARMACEUTICALS INC | 84763A108 | COM | 500,000 | $8,400,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 500,000 | $8,135,000 | thousands by filing date | |
| MINERVA NEUROSCIENCES INC COM NEW | 603380106 | Stock | 607,903 | $7,629,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 467,792 | $7,531,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 500,000 | $7,260,000 | thousands by filing date | |
| ABEONA THERAPEUTICS INC | 00289Y107 | COM | 500,000 | $6,400,000 | thousands by filing date | |
| CONTRAFECT CORP | 212326102 | COM | 3,000,000 | $6,210,000 | thousands by filing date | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 210,078 | $5,410,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 170,000 | $5,381,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 200,000 | $5,312,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 125,000 | $4,949,000 | thousands by filing date | |
| TRANSLATE BIO INC. | 89374L104 | Common Stock | 454,550 | $4,546,000 | thousands by filing date | |
| EIDOS THERAPEUTICS INC. | 28249H104 | Common Stock | 385,846 | $3,851,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 250,000 | $3,685,000 | thousands by filing date | |
| AKCEA THERAPEUTICS INC | 00972L107 | COM | 100,000 | $3,502,000 | thousands by filing date | put |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 200,000 | $3,390,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 238,579 | $3,245,000 | thousands by filing date | |
| ITERUM THERAPEUTICS PLC SHS NEW | G6333L101 | Stock | 476,968 | $3,196,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q101 | COM | 300,000 | $3,000,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 500,000 | $2,900,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 50,000 | $2,862,000 | thousands by filing date | |
| CLEARSIDE BIOMEDICAL INC | 185063104 | COM | 400,000 | $2,460,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 300,000 | $1,698,000 | thousands by filing date | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 54,945 | $1,177,000 | thousands by filing date | |
| ONCOBIOLOG-CW17A | 68235M113 | EQUITY WRT | 416,666 | $9,000 | thousands by filing date | |
| CELLECTAR BIOSCIENCES INC | 15117F120 | *W EXP 08/20/201 | 52,999 | $4,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001583977-18-000005 | this filing | 2018-11-14 | acceptance time not in the bulk data set |